Method of treating metabolic disorders and depression with dopamine receptor agonists
AssigneeVeroScience LLC
InventorAnthony H. Cincotta
Life of this patent
Estimating the term…
Abstract
This invention relates to methods and formulations for treating metabolic disorders and depression. In some embodiments, the methods comprise administering a dopamine receptor agonist and an anti-depressant.
Claims17
A method of treating type-2 diabetes and depression comprising administering to a patient in need thereof at different times of day a therapeutically effective combination of a dopamine receptor agonist and a serotonin enhancing agent, wherein the dopamine receptor agonist is administered at a first predetermined time of day in the morning and the serotonin enhancing agent is administered thereafter at a second predetermined time of day in the evening.
A method of treating depression and reducing the adverse effects of serotonin enhancing agents on type-2 diabetes in a patient which comprises administering to a patient in need thereof a therapeutically effective amount of a dopamine receptor agonist and a serotonin enhancing agent at different times of day, wherein the dopamine receptor agonist is administered at a first predetermined time of day in the morning and the serotonin enhancing anti-depressant agonist is administered thereafter at a second predetermined time of day in the evening.
Dependencies are inferred from the claim text.